{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:09:04Z","timestamp":1792195744771,"version":"4.4.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,20]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Intracellular cytokine production by peripheral blood mononuclear cells (PBMC) was analysed in 51 patients with multiple myeloma (MM), 22 with monoclonal gammopathy of undetermined significance (MGUS) and 20 healthy subjects, as a parameter of immunological dysfunction in MM. An increased proportion of T cells and HLA-DR+ cells producing IL-6 was observed in MM patients with active disease (at diagnosis and relapsing) compared with patients in remission and with MGUS, whereas no difference of IFN-\u03b3+, IL-2+ PBMC between patients and controls was evident. Determination of serum cytokine levels demonstrated that the imbalanced IL-6 production by T cells and the defective anti-tumour Th1 cell activity were related to elevated levels of IL-6 and IL-12. In vitro studies of PHA- and anti-CD3\/anti-CD28 MoAbs stimulation of PBMC demonstrated the ability of lymphocytes from MM patients to differentiate towards the Th1 subset in the presence of rIL-12. By contrast, addition of exogenous rIL-6 impaired IFN-\u03b3 production by rIL-12-prompted T cells. Inhibition of Th1 polarization of the immune response by IL-6 was direct on T cells and not mediated by dendritic cells (DC). Evaluation of the ability of MM-derived DC to stimulate cell proliferation of allogenic T lymphocytes and produce IL-12 in vitro, in fact, suggested that MM-derived DC were functionally active. Taken as a whole, these results indicate that a deregulated cytokine network occurs in active MM. They also suggest that increased IL-6 production by peripheral T lymphocytes contributes to the immune dysfunction observed in MM, and enables tumour cells to escape immune surveillance by preventing the anti-tumour Th1 immune response.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2001.01582.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:27:52Z","timestamp":1047360472000},"page":"190-197","source":"Crossref","is-referenced-by-count":69,"title":["Deregulated cytokine network and defective Th1 immune response in multiple myeloma"],"prefix":"10.1093","volume":"125","author":[{"given":"M A","family":"Frassanito","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cusmai","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Dammacco","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"2022011306430095700_b1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.8493532","article-title":"Identifying strategies for immune intervention","volume":"260","author":"Lanzavecchia","year":"1993","journal-title":"Science"},{"key":"2022011306430095700_b2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-065X.1999.tb01331.x","article-title":"Human tumor antigens for cancer vaccine development","volume":"170","author":"Wang","year":"1999","journal-title":"Immunol Rev"},{"key":"2022011306430095700_b3","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","article-title":"Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011306430095700_b4","first-page":"124","article-title":"Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte","volume":"55","author":"Frassanito","year":"1995","journal-title":"Cancer Res"},{"key":"2022011306430095700_b5","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood.V86.8.3043.3043","article-title":"Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies","volume":"86","author":"Yi","year":"1995","journal-title":"Blood"},{"key":"2022011306430095700_b6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"2022011306430095700_b7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.183.1.87","article-title":"Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines","volume":"183","author":"Zitvogel","year":"1996","journal-title":"J Exp Med"},{"key":"2022011306430095700_b8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4049\/jimmunol.159.2.664","article-title":"Type 1 vs type 2 cytokine released by V\u03b2 T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role","volume":"159","author":"Aruga","year":"1997","journal-title":"J Immunol"},{"key":"2022011306430095700_b9","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.158.7.3359","article-title":"IL-12 induces T helper-1 directed antitumor response","volume":"158","author":"Tsung","year":"1997","journal-title":"J Immunol"},{"key":"2022011306430095700_b10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.162.1.609","article-title":"High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer","volume":"162","author":"Fernandez","year":"1999","journal-title":"J Immunol"},{"key":"2022011306430095700_b11","first-page":"4035","article-title":"Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12","volume":"59","author":"Nishioka","year":"1999","journal-title":"Cancer Res"},{"key":"2022011306430095700_b12","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4049\/jimmunol.153.4.1697","article-title":"Recombinant IL-12 administration induces tumor regression in association with IFN-\u03b3 production","volume":"153","author":"Nastala","year":"1994","journal-title":"J Immunol"},{"key":"2022011306430095700_b13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI1555","article-title":"Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis","volume":"101","author":"Coughlin","year":"1998","journal-title":"J Clin Invest"},{"key":"2022011306430095700_b14","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1073\/pnas.69.6.1540","article-title":"Myeloma proteins as tumor-specific transplantation antigens","volume":"69","author":"Lynch","year":"1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011306430095700_b15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"2022011306430095700_b16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2141.1991.tb04384.x","article-title":"Anti-idiotypic antibodies in patients with monoclonal gammopathies. Relation to tumor load","volume":"78","author":"Bergenbrant","year":"1991","journal-title":"Br J Haematol"},{"key":"2022011306430095700_b17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/(sici)1097-0215(19990301)80:5&lt;671::aid-ijc7&gt;3.0.co;2-e","article-title":"T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma","volume":"80","author":"Fagerberg","year":"1999","journal-title":"Int J Cancer"},{"key":"2022011306430095700_b18","first-page":"705","article-title":"Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells","volume":"5","author":"Pellat-Deceunynch","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2022011306430095700_b19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood.V72.3.1064.bloodjournal7231064","article-title":"Activated idiotype-reactive cells in suppressor\/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status","volume":"72","author":"Dianzani","year":"1988","journal-title":"Blood"},{"key":"2022011306430095700_b20","first-page":"429","article-title":"A disturbance of the IL-2\/IL-2 receptor system parallels the activity of multiple myeloma","volume":"84","author":"Vacca","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011306430095700_b21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2141.2000.01981.x","article-title":"Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients","volume":"109","author":"Besostri","year":"2000","journal-title":"Br J Haematol"},{"key":"2022011306430095700_b22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1365-2141.1998.00589.x","article-title":"CD8+\/CD57+ cells and apoptosis suppress T-cell functions in multiple myeloma","volume":"100","author":"Frassanito","year":"1998","journal-title":"Br J Haematol"},{"key":"2022011306430095700_b23","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood.V85.12.3679.bloodjournal85123679","article-title":"Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients","volume":"85","author":"Massaia","year":"1995","journal-title":"Blood"},{"key":"2022011306430095700_b24","first-page":"243","article-title":"Multiple myeloma, macroglobulinemia and monoclonal gammopathies","volume-title":"Recent Advances in Haematology.","author":"Durie","year":"1977"},{"key":"2022011306430095700_b25","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"2022011306430095700_b26","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Beh\u00e7et's disease: a putative pathogenetic role of IL-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2022011306430095700_b27","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1182\/blood.V90.9.3482","article-title":"Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma","volume":"90","author":"Tarte","year":"1997","journal-title":"Blood"},{"key":"2022011306430095700_b28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1006\/clin.1996.0118","article-title":"Th1 and Th2 in human diseases","volume":"80","author":"Romagnani","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011306430095700_b29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon-\u03b3 production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D'Andrea","year":"1993","journal-title":"J Exp Med"},{"key":"2022011306430095700_b30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00062752-199704010-00010","article-title":"Function and clinical use of interleukin-12","volume":"4","author":"Trinchieri","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"2022011306430095700_b31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1365-2249.2000.01112.x","article-title":"Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients","volume":"119","author":"Haicheur","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022011306430095700_b32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1182\/blood.V85.3.765.bloodjournal853765","article-title":"Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group","volume":"85","author":"Pelliniemi","year":"1995","journal-title":"Blood"},{"key":"2022011306430095700_b33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1096-8652(199704)54:4&lt;335::aid-ajh15&gt;3.3.co;2-1","article-title":"Serum interleukin-10 in plasma-cell dyscrasias","volume":"54","author":"Stasi","year":"1997","journal-title":"Am J Hematol"},{"key":"2022011306430095700_b34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-5699(95)80125-1","article-title":"Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?","volume":"16","author":"Grabbe","year":"1995","journal-title":"Immunol Today"},{"key":"2022011306430095700_b35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2141.1997.3123128.x","article-title":"Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors","volume":"98","author":"Pfeiffer","year":"1997","journal-title":"Br J Haematol"},{"key":"2022011306430095700_b36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02826210","article-title":"Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma","volume":"17","author":"Hajek","year":"2000","journal-title":"Med Oncol"},{"key":"2022011306430095700_b37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1365-2141.1998.00633.x","article-title":"Anti-idiotypic T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells","volume":"100","author":"Dabadghao","year":"1998","journal-title":"Br J Haematol"},{"key":"2022011306430095700_b38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2141.1999.01669.x","article-title":"Serum interleukin-6 has no discriminatory role in paraproteinaemia nor a prognostic role in multiple myeloma","volume":"107","author":"Schaar","year":"1999","journal-title":"Br J Haematol"},{"key":"2022011306430095700_b39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells","volume":"185","author":"Rincon","year":"1997","journal-title":"J Exp Med"},{"key":"2022011306430095700_b40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/(sici)1521-4141(199801)28:01&lt;277::aid-immu277&gt;3.0.co;2-8","article-title":"Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF","volume":"28","author":"Joseph","year":"1998","journal-title":"Eur J Immunol"},{"key":"2022011306430095700_b41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jlb.61.1.80","article-title":"Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4","volume":"61","author":"Takenaka","year":"1997","journal-title":"J Leukoc Biol"},{"key":"2022011306430095700_b42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1074-7613(00)00078-9","article-title":"Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1","volume":"13","author":"Diehl","year":"2000","journal-title":"Immunity"},{"key":"2022011306430095700_b43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-2249.1998.00711.x","article-title":"Fas\/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells","volume":"114","author":"Frassanito","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"2022011306430095700_b44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V97.2.483","article-title":"Autocrine IL-6 production and highly malignant multiple myeloma: relationship with resistance to drug-induced apoptosis","volume":"97","author":"Frassanito","year":"2001;","journal-title":"Blood"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01582.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2001.01582.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/125\/2\/190\/42163260\/j.1365-2249.2001.01582.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/125\/2\/190\/42163260\/j.1365-2249.2001.01582.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T21:19:15Z","timestamp":1682111955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/125\/2\/190\/6461297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,12,20]]},"published-print":{"date-parts":[[2001,12,20]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01582.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,8]]},"published":{"date-parts":[[2001,8]]}}}